Starpharma Holdings (Starpharma Holdings) Other Income (Expense) : $0.79 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Starpharma Holdings Other Income (Expense)?

Starpharma Holdings's other income expense for the Starpharma Holdings's pretax income for the six months ended in Dec. 2023 was $0.38 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.79 Mil.

Starpharma Holdings Other Income (Expense) Historical Data

The historical data trend for Starpharma Holdings's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Other Income (Expense) Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Income (Expense)

Get a 7-Day Free Trial

0.22

1.01

1.74

0.94

0.89

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Income (Expense)	Get a 7-Day Free Trial															0.46	0.49	0.48	0.41	0.38

Starpharma Holdings Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.79 Mil.

Starpharma Holdings (OTCPK:SPHRF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRF) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

SPHRY:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.